|Articles|November 30, 2016
LabConnect Launches Data Integration Services
Advertisement
Seattle, WA. - LabConnect, a leading provider of highly customized global central laboratory and early development services to biopharmaceutical, medical device and contract research organizations, has announced the launch of its data integration services, which help sponsors coordinate complex, high-volume data collection and management from multiple laboratories’ data sources.
LabConnect’s enhanced, comprehensive data management capabilities streamline clinical trials by developing an infrastructure and coordinating logistics for programming, coding, cleaning and conditioning data that comes from a variety of sources.
By mapping and assembling the disparate data sources, standardizing data formats and merging, LabConnect provides superior data consistency, accuracy and usability. These outsourced solutions save sponsor resources and are particularly useful for delivering cohesive data for clinical projects, especially where timelines can be challenging.
“LabConnect’s robust data management services and tools provide sponsors improved speed, quality and continuity in their data,” said Eric Hayashi, president and CEO. “Data quality is ensured and documentation approved by the sponsor. We can often provide these services to our clients at a lower cost and with a faster turnaround than they can achieve keeping the tasks in-house, allowing them to remain focused on the core objectives of their clinical innovation.”
LabConnect’s enhanced, comprehensive data management capabilities streamline clinical trials by developing an infrastructure and coordinating logistics for programming, coding, cleaning and conditioning data that comes from a variety of sources.
By mapping and assembling the disparate data sources, standardizing data formats and merging, LabConnect provides superior data consistency, accuracy and usability. These outsourced solutions save sponsor resources and are particularly useful for delivering cohesive data for clinical projects, especially where timelines can be challenging.
“LabConnect’s robust data management services and tools provide sponsors improved speed, quality and continuity in their data,” said Eric Hayashi, president and CEO. “Data quality is ensured and documentation approved by the sponsor. We can often provide these services to our clients at a lower cost and with a faster turnaround than they can achieve keeping the tasks in-house, allowing them to remain focused on the core objectives of their clinical innovation.”
For more information about data integration and additional service areas, visit labconnectllc.com .
About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical, medical device and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory and early development service needs, from preclinical through Phase IV. Learn more atwww.labconnectllc.com or connect with LabConnect on LinkedIn .
About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical, medical device and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory and early development service needs, from preclinical through Phase IV. Learn more at
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
2
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
3
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
4
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
5